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Abstract
Interleukin-1b and Tumor Necrosis Factor a play related, but distinct, roles in immunity and disease. Our study revealed
major mechanistic distinctions in the Toll-like receptor (TLR) signaling-dependent induction for the rapidly expressed genes
(IL1B and TNF) coding for these two cytokines. Prior to induction, TNF exhibited pre-bound TATA Binding Protein (TBP) and
paused RNA Polymerase II (Pol II), hallmarks of poised immediate-early (IE) genes. In contrast, unstimulated IL1B displayed
very low levels of both TBP and paused Pol II, requiring the lineage-specific Spi-1/PU.1 (Spi1) transcription factor as an
anchor for induction-dependent interaction with two TLR-activated transcription factors, C/EBPb and NF-kB. Activation and
DNA binding of these two pre-expressed factors resulted in de novo recruitment of TBP and Pol II to IL1B in concert with a
permissive state for elongation mediated by the recruitment of elongation factor P-TEFb. This Spi1-dependent mechanism
for IL1B transcription, which is unique for a rapidly-induced/poised IE gene, was more dependent upon P-TEFb than was the
case for the TNF gene. Furthermore, the dependence on phosphoinositide 3-kinase for P-TEFb recruitment to IL1B paralleled
a greater sensitivity to the metabolic state of the cell and a lower sensitivity to the phenomenon of endotoxin tolerance
than was evident for TNF. Such differences in induction mechanisms argue against the prevailing paradigm that all IE genes
possess paused Pol II and may further delineate the specific roles played by each of these rapidly expressed immune
modulators.
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Introduction
Genome-wide approaches provide important insight into
general processes of gene regulation. However, such global studies
may result in a less detailed examination of mechanisms affecting a
small number of critical genes. For example, immediate-early (IE)
rapidly-induced, genes have been suggested to depend upon
paused RNA polymerase II (Pol II) arrested at a site approximately
50 bp downstream of the transcription start by engagement with
specific arresting factors. This constitutively paused state is thought
to poise the gene for IE elongation following an appropriate signal
[1]. A number of innate immunity genes respond to specific
external stimuli by rapid IE-like induction, requiring kinetic
evaluation of specific cell types treated with specific conditions that
have not been widely explored with regard to the mechanisms of
transcription regulation. In addition, many of these genes are
subject to transient expression resulting from epigenetic mecha-
nisms which rapidly shut-down transcription and render the gene
refractory to re-induction from a repeat of the same [2], but not of
a distinct [3] stimulus. In an attempt to better understand the
regulation of such induction, we have focused on human
interleukin-1b (IL1B) and tumor necrosis factor a (TNF), two
innate immunity genes which exhibit cell-type restriction, transient
IE induction, and conflicting reports of refractory re-induction,
also referred to as stimulant tolerance [2,3,4]. We employed a
combined approach using: cell lines and primary cells; reporter
transient transfection; chromatin immunoprecipitation; evaluation
of transcript integrity; ectopic expression in a non-competent cell
type; and comparison to mouse orthologs in order to determine
that an array of mechanisms interplay to distinctly regulate these
genes. Our kinetic approach provides novel insight into the
changes associated with Pol II recruitment, pausing and chromatin
dynamics along these genes. While transient induction of TNF was
associated with the expected IE mechanism, involving release of
the NELF elongation inhibitory factor from paused Pol II,
activation of IL1B depended on de novo recruitment of both TATA
binding protein (TBP) and RNA Polymerase II (Pol II) and likely
contributed to a slight induction delay. TBP has previously been
reported to directly interact with the monocyte lineage transcrip-
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tion factor Spi-1/PU.1 (Spi1) [5], consistent with our observation
that it appeared to be recruited to IL1B by this factor. We also
show that ectopic expression of Spi1, along with the Toll-like
receptor (TLR) surrogate TRAF6 in a cell line incompetent for
IL1B transcription, primed the endogenous genome for IL1B
induction by remodeling promoter nucleosomes and generated an
expanded nucleosome depleted region (NDR) that likely supports
the recruitment of TBP and Pol II in a manner reminiscent of that
observed in monocytes. In contrast to TNF, whose induction is
primarily dependent upon NF-kB [6], IL1B is co-dependent on
both C/EBPb [7,8,9] and NF-kB [10], transcription factors
simultaneously activated by lipopolysaccharide/Toll-like receptor
4 (LPS/TLR4) signaling [11,12] In support of previous transient
transfection and in vitro interaction studies arguing for a long range
interaction between a far-upstream bound C/EBPb and promoter
bound Spi1 [13,14], we observed a corresponding signal-
dependent chromatin loop for endogenous monocyte IL1B. With
regard to the LPS-unresponsive state known as endotoxin
tolerance, our data revealed that following transient induction,
IL1B and TNF remained marked with paused Pol II complexes for
up to 24 hours post-stimulation. Upon subsequent LPS exposure,
tolerized TNF remained in an unresponsive paused state, while
IL1B resumed transcription due to recruitment of the positive
elongation kinase P-TEFb. Emerging evidence suggests that
inflammatory responses of LPS/TLR4 activated macrophages
are interconnected with metabolic pathways, resulting in the shift
of energy utilization by the cells [15]. Here we report that
inhibition of either phosphoinositide 3-kinase (PI3K) or glucose
uptake had a greater affect on the transcriptional response of IL1B
than of TNF. The differences between these two genes, especially
for endotoxin tolerance, suggest that IL1B may play a distinct role
from TNF in chronic inflammation. It should also be noted that
the gene nomenclature in this paper varies with species.
Specifically, human genes are represented by all uppercase gene
designations (e.g., IL1B, TNF), whereas mouse loci are designated
by the capitalization of only the first letter (Il1b, Tnf).
Results
IL1B and TNF mRNA are Differentially Expressed in
Monocytes
Steady-state mRNA kinetics of IL1B and TNF in human (THP-
1) and murine (RAW264.7) monocyte cell lines, as well as primary
macrophages, revealed differences in transcription responses. TNF
displayed rapid induction and complete transcription shut down
within a few hours of LPS treatment. In contrast, IL1B was also
rapidly induced, but not completely switched off, with continued
expression for many hours post-stimulation (Figures 1A, S1A–C).
Transient expression patterns for these genes are reflective of their
transcription because of short mRNA half-life mediated by AU-
rich element (ARE) degradation, especially during the first 5 h
after induction for IL1B message, as reported for THP-1 cells
[3,16]. In resting monocytes, basal levels of full-length unspliced
TNF, but not IL1B, transcripts were detected (Figure S1D). It has
been hypothesized that low levels of constitutive transcription
favors accessible chromatin and transcription competence for IE
gene activation [17]. RNA polymerase II (Pol II) ChIP-qPCR was
used in order to directly measure the transcription status of
monocyte IL1B and TNF (Figures 1C, S2A). Pol II occupancy
kinetics, particularly in THP-1 cells (Figure 1C), mimicked the
respective steady-state mRNA profiles confirming that sustained
expression of IL1B shown in Figure 1A resulted from continuous
polymerase engagement and not from increased mRNA stabiliza-
tion. Kinetic analysis of the transient phase of THP-1 gene
activation revealed a 30 minute delay in Pol II recruitment to IL1B
(Figure 1D), consistent with the observed mRNA delay (Figure
S1E). In contrast, increased Pol II binding on TNF was detected as
early as 15 min following LPS stimulus. We next asked, whether
the differential shutdown of these genes corresponded to
differences in tolerance after exposure to secondary LPS stimulus.
We observed that both mouse and human genes coding for TNFa
were tolerized, so that once induced they could not be re-
stimulated. A previous report argued that murine Ilib and Tnf are
both refractory to reactivation due to mechanisms commonly
recognized as endotoxin tolerance [2]. In contrast to that report, in
which cells were washed prior to re-stimulation, we observed
significant transcription of genes coding for IL-1b after repeated
LPS exposure in THP-1, RAW264.7, and human primary
macrophages stimulated with LPS followed by an equal 2.5 h
secondary dose added to unwashed cultures (Figure 1A, arrows,
boxes and dotted lines). Western blot analysis demonstrated that
secondary stimulation of IL1B resulted in expression of the
31 KDa proIL-1b precursor protein, but not the 26 KDa
precursor for TNFa (Figure 1B). Strikingly, these results recapit-
ulate an earlier report that in vivo injection of a sub-lethal dose of
LPS into mice resulted in TNF, but not IL-1 tolerance in serum
[4]. Similarly, steady-state kinetic mRNA secondary stimulation
revealed that IL1B transcription is not tolerized (Figure 1A).
Pol II Pausing and the P-TEFb:NELF Axis Contribute to
Differential Transcription Shutdown of IL1B and TNF
IE gene activation associated with signal dependent release of
pre-loaded Pol II facilitates rapid gene transcription [18,19]. Since
IL1B and TNF are immediately transcribed in activated mono-
cytes, promoter Pol II enrichment was examined. TNF exhibited a
significant Pol II peak (centered at +57), downstream of the
transcription start site (TSS) in resting THP-1 and human primary
macrophages (Figure 1C). A significant amount of paused Pol II
(centered at +36) at IL1B was prominent only in LPS stimulated
cells (Figures 1C, S2A, S2B). Consistent with elongation, LPS
activation caused increased Pol II throughout transcribed regions
of both genes. Differential TBP binding between IL1B and TNF in
resting and induced cells, supports differential Pol II pre-
association for these genes (Figures 2A, S2A). The sites of paused
Pol II were associated with inducible short transcripts (Figure 2B,
upper panels) sensitive to the specific transcription factor inhibitors
U0126 for C/EBPb and MG132 for NF-kB (Figure 2B, lower
panels). While MG132 blocks proteosome degradation of
the inhibitory IkB protein [20], U0126 blocks the
activation of ERK/MAPK phosphorylation pathway
[21,22]. In agreement with Pol II ChIP, basal TNF transcription
in unstimulated monocytes was further confirmed with this
technique. TNF data closely resembled that of classically paused
JunB (Figure S2C). Control HIST1H4K gene transcript amplifica-
tion was constitutively expressed (Figure 2B). Pol II dynamics for
murine RAW264.7 cells and bone marrow derived macrophages
(BMDM) confirmed similar differences between Il1b and Tnf
(Figure S3A,B).
Phosphorylation of Pol II carboxy-terminal domain (CTD) and
recruitment of cofactors, such as NELF and P-TEFb are important
indicators of initiation, pausing and elongation [23]. Figure 2A
shows kinetics for indicators of transcription elongation for LPS-
treated THP-1 cells. As expected, enrichment of Pol II S5P CTD
is confined to promoter proximal regions, whereas S2P CTD in
LPS-stimulated monoctyes increased toward the 39 end of both
genes. Increased binding of NELF to paused Pol II on TNF was
diminished within 1 h. As transcription concludes, around 5 h
post stimulation, NELF binding to TNF returned to pre-
Not All Immediate Early Genes Are Created Equal
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Figure 1. Comparison of IL1B and TNF expression in monocytes. (A) Steady-state mRNA kinetics for IL1B and TNF transcripts in LPS stimulated
THP-1, RAW264.7 and human peripheral blood mononuclear cells (hPBMC). Solid lines denote mRNA levels for primary LPS challenge. Squares show
Not All Immediate Early Genes Are Created Equal
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stimulation levels. NELF ChIP for IL1B revealed distinct binding
with increased enrichment at later time points, confirming the lack
of a Pol II pause in resting monocytes. P-TEFb was coordinately
recruited to the promoters of both genes, but in contrast to TNF,
its binding was maintained on IL1B at 5 hours in THP-1 cells,
although at a lower level than at 1 h (Figure 2A) and significantly
prolonged in BMDM (Figure S3B) and likely contributed to
sustained expression. P-TEFb inhibitor 5,6-dichloro-1-beta-D-
ribofuranosylbenzimidazol (DRB) blocked transcription and
maintained Pol II at the proposed paused sites (Figure 2A,B),
demonstrating the significance of P-TEFb in inducible control of
IL1B and TNF.
Pol II S2P CTD Differentially Influences IL1B and TNF
Endotoxin Tolerance
ChIP revealed a significant amount of promoter Pol II on both
genes in 25 h stimulated monocytes, with decreased signal
downstream of the pause sites (Figure 2C). Pol II occupancy
within the gene was slightly higher for IL1B, likely explaining its
sustained transcription profile. NELF was co-localized with
promoter bound Pol II on both genes (Figure 2C). Our data
revealed that upon secondary stimulation, P-TEFb was re-
recruited to the IL1B promoter, resulting in resumption of
elongation. This is in contrast to tolerized TNF, in which P-TEFb
recruitment and S2P CTD levels were not increased in re-
stimulated cells (Figure 2C). The results suggest that low levels of
sustained expression may sufficiently maintain IL1B competency
for secondary re-induction by the means of gene-specific liberation
of the Pol II pause by P-TEFb during repeated LPS exposure, a
situation that fails to occur on TNF. These data argue that
secondary induction of IL1B is a physiologically significant
phenomenon that further distinguishes it from TNF.
LPS Stimulation of Monocytes Results in Dynamic
Changes in Nucleosome Positioning and Modification on
IL1B and TNF
Nucleosome position plays a critical role in promoter accessi-
bility, and genome-wide studies have shown that Drosophila and
human promoters are commonly devoid of nucleosomes [24,25].
Stalled Pol II serves as a physical barrier, preventing promoter
nucleosome assembly and formation of repressive chromatin,
enabling gene expression [26]. To address the question of
chromatin influence on these two genes, promoter nucleosome
occupancy was examined using core histone 3 (H3) ChIP [24,27]
in resting and stimulated THP-1 monocytes, HEK293 pre-
neuronal cells that express neither IL1B nor TNF, and HUT102
cutaneous T lymphocytes that constitutively express TNF
(Figure 3A). We observed +1 nucleosomes on both genes
approximately 200 bp downstream of TSS. A similar observation
was reported for Drosophila Hsp70 promoter [28]. The distribution
of weakly positioned nucleosomes, upstream of TSS, was unique to
each gene. In particular, the 21 nucleosome on TNF was located
approximately 40 bp upsteam of the TSS, whereas on IL1B it was
focused further downstream in the vicinity of the TSS. We
observed a significant depletion of promoter bound nucleosomes
in 1 h-stimulated monocytes, similar to that reported for activated
genes [29]. The extent of nucleosome depletion was reduced in
cells pretreated with inhibitors U0126 and MG132 selective for
transcription factors associated with induction of one or both genes
(Figures 3A). Therefore, this depletion is stimulation dependent,
requiring specific factor recruitment. It is noteworthy that IL1B
nucleosome displacement was sensitive to both inhibitors, whereas
TNF was almost exclusively affected by MG132, suggesting that
C/EBPb is specifically required for IL1B. Five hours post-
stimulation, as Pol II recruitment levels decline, depleted
nucleosomes recovered, approaching initial enrichment levels for
the +1 nucleosome of TNF. In contrast, IL1B nucleosome
depletion exhibited only a partial recovery. In addition, cells
pre-treated with either inhibitor revealed a striking increase in the
21 IL1B nucleosome, an additional distinction from TNF. The
presence of uniquely phased 21 nucleosomes in promoter NDR
has been suggested to inhibit Pol II recruitment [30,31], but to our
knowledge this is the first report indicating its role affecting
inducible IE activation in human immune cells and may reflect
loss of an important priming function for this gene. The IL1B and
TNF nucleosomes in HEK293 exhibited higher levels, especially
for the 21 nucleosome. Nucleosomes were similarly more
abundant on IL1B in Hut102 than in THP-1, with higher levels
at 22 and +1. The constitutive expression of TNF in Hut102
revealed a profile similar to that for 1 h stimulated THP-1 cells
(Figure 3A).
To further understand the processes regulating IE gene
architecture and LPS induction, the spatial-temporal distribution
of chromatin marks on IL1B and TNF was investigated (Figure 3B,
S4). LPS caused changes in nucleosome marks on both genes. We
observed the absence of repressive H3K27me3 and high levels of
permissive H3K4me3 in monocytes that likely contributes to LPS
responsiveness [32]. H3K4me3, a mark of promoter regulatory
elements that indirectly facilitates TBP recruitment [33], did not
show a significant 1 h post-LPS increase in the vicinity of +1
nucleosomes. Surprisingly, enrichment of this mark revealed
delayed kinetics on IL1B and followed Pol II recruitment, as
shown by an increase at 5 h. Higher levels of H3K4me3 at 5 h
remained mostly at the IL1B promoter, but spread throughout the
body of the TNF gene. The distinct positional effect of H3K4me3
near the promoter versus the downstream region of genes has
previously been observed [34], and may be critical for differences
between IL1B and TNF. The relative levels of the activating
H3K9ac mark on the +1 nucleosome and of heterochromatic
H3K9me3 on downstream nucleosomes within the gene body,
suggest a possible relationship with post-stimulatory tolerance for
TNF. Prior to stimulation both genes were associated with
permissive levels of H3K9ac at the +1 nucleosome, supporting
gene expression competency. Importantly, H3K9ac levels were
initially very low in the vicinity of the IL1B upstream enhancers,
but were significantly increased at 1 and 5 h post-stimulation.
Examination of nucleosome marks at the promoters for these
genes (Figure 3B) normalized to the relative H3 levels on
nucleosome +1 at each time point (Figure 3, Table S1 in File
S1), suggest that the significant levels of H3K9ac on +1 did not
appear to significantly increase in either gene at 1 h post-
stimulation. For IL1B, the 21 nucleosome, in contrast to that at
transcript levels following re-stimulation, as indicated by arrows. (B) Western blot for 30 KDa proIL-1b precursor protein. (C) Pol II ChIP throughout the
IL1B and TNF loci in resting (black), 1 h (red) and 5 h (green) LPS stimulated THP-1, RAW264.7 and hPBMC cells. Vertical gray bars locate the positions
of important gene landmarks. These include TATA box and the canonical Pol II pause position (approximately 30 bp upstream and 50 bp downsteam
of TSS, respectively). (D) Pol II ChIP at promoter and downstream sites for IL1B and TNF. E. Schematic of IL1B and TNF gene structures showing exons
(solid boxes), positions of ChIP amplicons (midpoint relative to TSS), and important transcription factor binding sites (C: C/EBPb, k: NF-kB and S: Spi1)
within regulatory regions (open boxes).
doi:10.1371/journal.pone.0070622.g001
Not All Immediate Early Genes Are Created Equal
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+1, revealed at least a 10-fold increase in H3K9ac by 1 h that
persisted at 5 h post-stimulation. In contrast to IL1B, 5 h post-
stimulated TNF uniquely exhibited a large increase in H3K4me3
throughout the gene body, with a lesser increase than IL1B in
Figure 2. Distribution of factors relevant to differential transcription regulation and endotoxin tolerance for IL1B. (A) ChIP for factors
related to Pol II elongation at IL1B and TNF loci in THP-1 cells. (B) Steady-state mRNA kinetic positional profiles for IL1B, TNF and control gene
transcripts, as indicated, in LPS stimulated THP-1. (C) ChIP for IL1B and TNF during secondary LPS stimulation of THP-1 cells. The solid and dotted plots
represent primary and secondary LPS treatment, respectively, of THP-1 cells at indicated times. Thin gray plot denotes 1 h LPS reference curve. For all
panels, along with the two gene landmarks in Figure 1C, an additional vertical gray bar designates the location of an important NF-kB binding site
(near 2300 bp) for IL1B.
doi:10.1371/journal.pone.0070622.g002
Not All Immediate Early Genes Are Created Equal
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H3K9ac at the +1 nucleosome. At 5 h H3K4me3 is increased
more selectively over the +1 nucleosome along with H3K9ac. It is
possible that this distinction maintains the sustained elongation
and resistance to tolerance for IL1B. High levels of the H3K9me1
promoter-proximal mark were distributed throughout the tran-
scribed gene body of IL1B and TNF in resting monocytes, a
phenomenon reported by others with unknown functional
significance [35]. In contrast to H3K9ac, the H3K9me1 was
rapidly lost following LPS treatment (Figure S4). The high levels of
H3K9me1 in the non-monocytic cell lines suggest that this mark
might contribute to gene suppression when present at sites distal
from the TSS. We hypothesized that the TLR4-dependent
activation of IL1B and TNF caused replacement of the repressive
H3K9me1 mark with a transcriptionally permissive one, which
may have contributed to the expression of both genes.
The Pol II elongation footprint marked by H3K36me3 [36]
revealed a consistent LPS-induced transient enrichment pattern
that increased toward the 39 ends of both genes. In contrast to
IL1B, significant levels of H3K36me3 were detected on the TNF
locus in unstimulated monocytes, further confirming constitutive
basal activity. The spatial distribution of chromatin modifications
at IL1B and TNF loci were also assessed for Hut102 and HEK293
cells. Pol II levels and chromatin marks for TNF in Hut102 were
consistent with active transcription, as previously reported [37],
whereas IL1B was repressed (Figure 3B). TNF in Hut102 revealed
low, but significant, levels of promoter-proximal H3K4me3, and
moderate levels of H3K27me3. This combination is a ‘‘bivalent’’
Figure 3. Nucleosome positioning dynamics and modifications during IL1B and TNF induction. (A) Kinetic ChIP of histone 3 (H3) for IL1B
and TNF in THP-1 and control Hut102 and HEK293 cells, as indicated. Key nucleosomes are designated by position relative to the TSS (22,21, +1). (B)
ChIP for histone modifications at IL1B and TNF, as indicated for each cell line. All panels are similarly scaled with respect to spatial distribution along
each gene, permitting comparative localization. For all panels, along with the three gene landmarks in Figure 2, an additional vertical gray bar
designates the approximate location of the far-upstream enhancer (23000 bp) for IL1B.
doi:10.1371/journal.pone.0070622.g003
Not All Immediate Early Genes Are Created Equal
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mark [32], indicative of inactive/poised developmental induction.
Nevertheless, TNF in these HTLV-1 infected malignant T cells is
constitutively expressed, suggesting a more complex means of gene
regulation. HEK293 did not show positive indicators for either
gene and exhibited only the inhibitory H3K27me3 on both. The
repressive H3K27me3 extended throughout the length of both
genes, but appeared to be more focused over the TNF gene body,
while for IL1B the mark was more prominent over the potent LPS
enhancer near 23000, which binds C/EBPb [38], and the key
NF-kB site near 2300 [10].
Spi1 Mediates Monocyte-specific IL1B Expression
Evaluation of the spatial-temporal distribution of selected
transcription factors revealed that IL1B is dependent upon a
different set of regulators than TNF. A major factor involved in
genome-wide priming of LPS responsive enhancers [39,40] and
maintenance of the macrophage lineage is the ETS domain DNA
binding factor Spi1 [41]. We previously reported that vigorous
IL1B transcription depends on Spi1 binding both to the IL1B
promoter [9] and to a poised monocyte-specific enhancer,
requiring cooperative association of Interferon regulatory factor
8 (IRF8) and non-tyrosine phosphorylated (NTP)-Stat1 [42]. In
agreement with this, constitutive association of Spi1 at the IL1B
promoter and enhancer persisted for an extended time post
induction (Figure 4A). In contrast, Spi1 was significantly less
abundant on TNF (Figure 4A). We hypothesized that in addition
to its role priming enhancers, Spi1 binding at the IL1B promoter
mediates cell-type restricted transcription competency. To exam-
ine the role of this ‘‘pioneer factor’’ in IL1B induction, transient
transfection studies were carried out in HEK293 cells, which do
not transcribe IL1B. Initial screens revealed the absence of Spi1 in
these cells as compared to THP-1 (Figure 4B). Since HEK293 do
not express the TLR4 LPS receptor, co-transfection of TNF
receptor-associated factor 6 (TRAF6) was used as a dominant-
positive LPS surrogate in these cells [43]. Figure 4C shows that an
IL1B reporter vector (XT-Luc) was potently up-regulated by Spi1
in combination with IRF8, a factor important for full IL1B activity
in monocytes [42] and absent in HEK293, and dominant-positive
TRAF6. IRF8 and TRAF6 alone (Figure S5A) or in combination
were insufficient for IL1B induction. Spi1 function requires the
integrity of its N-terminal TBP Binding Domain (TBD) [9]. In
agreement, ectopic expression of a dominant-negative Spi1
mutant (dn/Spi1), containing only the Spi1 DNA binding domain,
reduced XT-Luc activity to background levels. Analysis of
endogenous IL1B mRNA in HEK293 transfected with the same
factors supported the luciferase assay results as well as the critical
role of Spi1 for IL1B induction (Figure 4D). Basal level of IL1B
transcription in cells transfected only with Spi1 was increased by
Figure 4. Spi1 mediates monocyte-specific IL1B expression. (A) Spi1 ChIP for IL1B and TNF in control and LPS-treated THP-1 cells. (B)
Transcription factor mRNA expression profiles in HEK293 and THP-1 cells. A third panel (and data in Figure S5H) displays ectopic mRNA expression of
Spi1 in transfected HEK293. (C) IL1BXT-Luc reporter activity for ectopic expression of indicated factors in HEK293. (D) Endogenous IL1B mRNA
expression in transfected HEK293. (E) ChIP for endogenous TBP, Pol II and H3 with ectopic Spi1 in HEK293. Vertical gray bars designating important
gene landmarks are as described in Figure 3.
doi:10.1371/journal.pone.0070622.g004
Not All Immediate Early Genes Are Created Equal
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addition of IRF8 and TRAF6. Substitution of wild type with dn/
Spi1 abolished IL1B expression. TNF expression in Spi1 trans-
fected HEK293 was unaffected (Figure S5B.). Since the N-
terminal TBD of Spi1 directly interacts with TBP [5], we tested
whether Spi1 plays a role in recruitment of TBP to the IL1B
promoter by performing ChIP in HEK293 transfected with either
wild type or dn/Spi1 in combination with IRF8 and TRAF6. As
shown in Figure 4E, transfection of Spi1 and the auxiliary factors
increased TBP occupancy at the IL1B TATA box. We observed
recruitment of Pol II to IL1B downstream of TSS, reminiscent of
paused polymerase, as well as to the transcribed region of the gene,
consistent with elongation. TBP and Pol II occupancy in HEK293
transfected with dn/Spi1 were dramatically reduced. Transfec-
tion-induced IL1B activation was also associated with depletion of
promoter proximally phased nucleosomes. Figure 4E shows that
full length Spi1 in combination with TRAF6 and IRF8 were
necessary for IL1B promoter nucleosome depletion. These data
suggest that Spi1 plays a critical role at the IL1B, but not the TNF
promoter. In addition to facilitating IL1B promoter accessibility
[44], the Spi1 TBD may play a role in general transcription
machinery recruitment by TBP.
LPS-activated C/EBPb Interaction with Spi1 Differentiates
Induction of IL1B and TNF
Endotoxin dependent binding of NF-kB has been shown to play
an important role during induction of IL1B and TNF in monocytes
[10,45] and Spi1 may facilitate NDR formation by exposing
binding sites for LPS-responsive transcription factors [46]. Kinetic
ChIP analyses revealed transient binding of NF-kB to both genes
within 30 minutes of LPS treatment, which was diminished by pre-
treatment of THP-1 with either the NF-kB-targeted proteasome
inhibitor MG132 or the IkB kinase inhibitor BMS-345541
(Figure 5A). Concomitantly, mRNA levels of both genes were
significantly reduced (Figure S5C–E). Earlier in vitro studies
demonstrated the involvement of C/EBPb in IL1B induction
[8,47]. Using ChIP to evaluate in vivo binding kinetics for C/EBPb
in LPS-stimulated cells revealed LPS-mediated recruitment of C/
EBPb to the IL1B, but not to the TNF promoter (Figure 5A). The
U0126 MEK1/2 pathway inhibitor was chosen in order to target
the activation of C/EBPb. LPS activated monocytes pre-treated
with U0126 revealed decreased IL1B transcription (Figure S5E),
consistent with reduced C/EBPb binding (Figure 5A), while TNF
expression was unaffected. Transient transfection of HEK293 was
used to clarify the role of these inducible transcription factors. NF-
Figure 5. LPS-activated C/EBPb interaction with Spi1 differentiates induction of IL1B and TNF. (A) NF-kB and C/EBPb ChIP for THP-1 cells,
as indicated. (B) Effect of ectopic expression of IkBa super repressor (IkBaSR) on IL1B XT-Luc reporter activity in HEK293 cotransfected with indicated
factors. (C) Effect of dnC/EBPb titration on IL1B XT-Luc reporter activity in HEK293. (D) Effect of C/EBPb and NF-kB binding site mutations on IL1BXT-
Luc reporter activity in RAW264.7. (E) XT-Luc reporter activity, as indicated in HEK293 cotransfected with C/EBPb, NF-kB and Spi1 siRNA. (F) P-TEFb
and (G) BRD4 ChIP in THP treated, as indicated.
doi:10.1371/journal.pone.0070622.g005
Not All Immediate Early Genes Are Created Equal
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e70622
kB and C/EBPb were ineffective IL1B inducers when transfected
alone into HEK293, but significant activation of IL1B was
observed when the factors were transfected in combination with
Spi1 (Figures 5B, S5F). Co-expression with TRAF6 showed the
strongest activity (Figure S5F). Over-expression of an IkBa super
repressor (IkBaSR), [48] considerably reduced, but did not
completely abolish, IL1B activity in HEK293 transfected with
Spi1, TRAF6 and C/EBPb (Figure 5B). Experiments in murine
RAW264.7 monocytes further demonstrated that IkBaSR fully
eliminated NF-kB activity without completely inactivating IL1B
XT-Luc (Figure S5G). In addition, titration of truncated, dn/C/
EBPb [8] in HEK293, confirmed dose dependent inhibition of
IL1B activity (Figure 5C). To further demonstrate the importance
of NF-kB and C/EBPb for IL1B induction, RAW264.7 cells were
transiently transfected with a modified IL1B XT-Luc reporter
harboring mutations within the essential NF-kB (near 2300) and
C/EBPb (I-Region/Enhancer) binding sites. As shown in
Figure 5D, disrupted binding of these two factors severely reduced
responsiveness of IL1B reporter to LPS. Lastly, siRNA for NF-kB
and C/EBPb in HEK293 revealed significant reduction of IL1B
XT-Luc activity (Figure 5E). In agreement with our previous
results, depletion of Spi1 caused severe reduction of IL1B reporter
activity (Figure 5E). The data presented here, challenge the
popular notion that NF-kB is the only critical LPS-activated factor
potently affecting IL1B induction. It appears that NF-kB and C/
EBPb cooperatively regulate LPS induced transcription of IL1B,
while expression of TNF appears to be influenced primarily by NF-
kB.
We next explored the relationship between the factors and
dynamics of paused Pol II release during transcription of IL1B and
TNF by examining P-TEFb ChIP for LPS stimulated THP-1 cells
pre-treated with specific transcription factor inhibitors. Inhibition
of NF-kB activation by MG132 resulted in significant depletion of
P-TEFb recruitment to both genes (Figure 5F). This is consistent
with reports that NF-kB interacts with and activates P-TEFb [49].
There was also a rapid-transient recruitment of the bromodomain-
containing protein BRD4 to TNF within 30 minutes of LPS
stimulation, whereas occupancy of BRD4 on IL1B was less
prominent (Figure 5G). BRD4 is an atypical kinase reported to
phosphorylate Pol II S2 CTD [50], which is recruited to NF-kB
p65 phosphorylated at Ser 276 by MSK-1 MAP kinase [49].
These results suggests a possible novel role for C/EBPb as an
adaptor, mediating the recruitment of P-TEFb to the IL1B
promoter. As expected, only minor changes in P-TEFb occupancy
at the TNF promoter were observed in U0126 exposed cells.
Transcription Factor Mediated Looping between the IL1B
Distal Enhancer and Promoter
Previous reports have identified far-upstream enhancers,
positioned 23000 bp from the TSS for human IL1B and 22200
for mouse Ilib, as critical for robust induction [38,51]. Recent
genome-wide studies in murine macrophages demonstrate that
LPS responsive enhancers have common features marked by
inducible p300 binding and H3K4me1 modification [39,40]. Our
analysis of H3K4me1 revealed significant enrichment of this mark
throughout the transcribed regions of IL1B and TNF, as well as at
the 23000 bp far-upstream IL1B enhancer (Figure S4). In
agreement with robust LPS-mediated p300 binding (Figure 6A),
we observed that H3K9 acetylation levels increased throughout
the enhancer in LPS stimulated monocytes (Figure 3B). Chromo-
somal interactions between distal elements have been implicated in
regulating gene expression [52]. The dynamic association of
enhancers and promoters can be mediated by protein-protein and
protein-DNA or RNA interactions among transcription factors
and chromatin modifiers, ultimately leading to enhanced initiation
[53]. On the basis of in vitro studies, functional cooperation
between enhancer bound C/EBPb and promoter bound Spi1
DNA looping was previously proposed as a mechanism for IL1B
induction [14,54]. We used chromosome conformation capture
(3C) to examine LPS-dependent in vivo long-range chromosomal
interactions between the IL1B enhancer and promoter. Figure 6B
reveals LPS-dependent physical association between IL1B distal
and proximal regulatory elements. The NF-kB and C/EBPb
inhibitors abolished LPS dependent chromosome loop formation
(Figure 6B), transcription (Figure S5E), nucleosome depletion
(Figure 3A) and Pol II recruitment to the IL1B promoter
(Figure 6C), revealing that chromosome looping correlates with
the binding of C/EBPb and NF-kB. In addition to interacting with
C/EBPb, the DNA binding domain of Spi1 interacts in vitro with
NF-kB (Figure S5I). These data suggest that endotoxin activation
of both C/EBPb and NF-kB may contribute to dynamic
juxtapositioning of the distal regulatory elements of IL1B by
common association with two critical Spi1 binding sites previously
mapped to the IL1B promoter [9], resulting in the formation of a
chromatin complex favorable for gene induction (Figure 6D).
Metabolic Effects on Transcription Regulation of Il1b and
Tnf
Since P-TEFb recruitment to IL1B, in contrast to TNF,
appeared to be less dependent upon BRD4 and more dependent
upon C/EBPb, distinct pathways for P-TEFb activation by release
from the inhibitory 7SK RNP complex [1] were considered. One
of these is the possible involvement of PI3K as an activator of Akt/
PKB kinase, which has been reported to activate P-TEFb by
directly phosphorylating Hexim1 in 7SK RNP [55]. Figure 7A
reveals that the PI3K inhibitor LY-294002 had a greater effect on
P-TEFb recruitment to Il1b than to Tnf in LPS-treated RAW264.7
cells. Interestingly, ligand-mediated activation of both TLR and
IL-1 receptors not only induces IL1B transcription, but also
directly recruits and activates PI3K [56,57], consistent with the
proposed role for PI3K and Akt in P-TEFb activated induction.
This result was of particular interest to us because we have recently
reported that the non-metabolizable glucose analogue and
hexokinase inhibitor 2-deoxyglucose (2-DG) [58], which directly
inhibits glycolysis and ATP synthesis, more effectively inhibits
IL1B than TNF in a manner that is dependent upon the
stabilization of the HIF-1a transcription factor binding to IL1B
under normoxia conditions approximately 4 h after LPS induction
[59]. Figure 7B reveals the presence of significantly higher levels of
Pol II and Pol II S5P CTD on Tnf than on Il1b for 4 h LPS
stimulated murine BMDM pretreated with 2-DG. This result is
consistent with reduced levels of Pol II S2P CTD, P-TEFb and
H3K36me3 relative to Pol II on Il1b. (Figure 7B). Overall, the
greater sensitivity of Il1b elongation to the metabolic state of the
cell may position P-TEFb as a critical regulator of inflammatory
responses.
Discussion
The induction of IL1B and TNF involves a stringently regulated
sequence of events triggered by the detection of LPS by TLR4.
Previous reports suggest that IE gene activation is associated with a
pre-assembled promoter transcription machinery [17,60]. Paused
Pol II and a depleted nucleosome architecture favors the
immediate response to stimuli by transitioning into a state of
processive elongation [61]. Although IL1B and TNF are both
classified as TLR4-dependent IE genes, we observed that their
transcription was differentially regulated in LPS treated mono-
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cytes. Our detailed kinetic analysis of transient vs. sustained
expression provides novel insight into changes associated with
induction, shutdown, and the potential for reactivation of these
genes. In particular, changes in transcription factor recruitment
and nucleosome occupancy may all contribute to the rapid gene-
specific induction of these IE responders. Figure 8A summarizes
some of the relevant data, along with a detailed model in
Figure 8B. In unstimulated cells, the TNF promoter contains
significant pre-bound TBP and NELF-dependent paused Pol II.
The pre-assembled components of the transcription machine likely
contribute to the observed constitutive transcription leakiness of
TNF, priming it for rapid induction. Therefore, TNF fits the
current models for IE gene induction involving prebound TBP
[62] and paused Pol II. Quiescent IL1B is initially more stringently
regulated, recruiting very low levels of TBP and Pol II. The initial
induction of IL1B is primarily dependent upon LPS-dependent Pol
II recruitment, followed secondarily by a transient DRB-sensitive
and p-TEFb-dependent Pol II pause. The Pol II peaks on TNF
and IL1B are associated with short nascent transcripts whose levels
correlate with temporal binding of enzyme and inhibitor
sensitivity. Phosphorylation of NELF and S2P CTD, mediated
by P-TEFb, transitions Pol II to elongation. The slower initial
expression of IL1B as compared to TNF correlates with a similar
delay in Pol II recruitment, arguing for an upstream rate-limiting
step, which could be related to the de novo recruitment of TBP and
Pol II. Interestingly, the 3C results, demonstrating the existence of
a chromatin loop, consistently revealed the prevalence of one
recombination product, suggesting the possibility of a preferred
conformational proximity for the upstream and downstream IL1B
sequences. Such preformed chromatin architecture has been
observed for cells at specific developmental stages [63]. Here we
show that LPS-inducible binding of NF-kB to TNF facilitates
recruitment of BRD4, and subsequently P-TEFb, consistent with
previous studies of murine macrophages [17]. In contrast to TNF,
both NF-kB and C/EBPb appear to mediate BRD4-independent
recruitment of P-TEFb to IL1B (Figure 5F,G). Additionally, we
argue that PI3K and Akt-mediated activation of P-TEFb
selectively contributes to Il1b elongation in murine macrophages.
Since metabolic imbalance affects PI3K/Akt signaling, a disrup-
tion of glucose availability in stimulated monocytes may cause
selective inhibition of Pol II elongation on Il1b. The effect of 2-DG
on p-TEFb recruitment to IL1B further emphasizes intriguing
Figure 6. LPS-dependent p300 binding and transcription factor-mediated promoter-enhancer looping at IL1B. (A) Inducible p300
binding at IL1B and TNF. (B) Schematic representation of PCR primer pairs used for evaluating 3C ligation products (Left) and PCR assessment of 3C
ligation restriction fragment products in the absence and presence of U0126 and MG132 inhibitors. (C) Effects of U0126 and MG132 inhibitors on Pol
II ChIP for IL1B and TNF, as indicated. (D) Model for chromatin looping during activation of IL1B.
doi:10.1371/journal.pone.0070622.g006
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connections between cell metabolism and transcription regulation
of an important pro-inflammatory gene (Figure 8C). Our data
provide evidence that IL1B and TNF promoters maintain paused
Pol II for up to 25 h after their initial burst of transient
transcription. Secondary stimulation re-recruits P-TEFb to IL1B,
resulting in resumption and maintenance of transcription elonga-
tion in a manner more similar to classic IE genes. This contrasts
tolerized TNF, in which secondary recruitment of P-TEFb and
S2P modification of Pol II are absent, repressing the gene for
extended time periods following vigorous transient transcription.
Figure 7. Distinct metabolic sensitivity for transcription elongation on Il1b and Tnf in murine bone marrow-derived monocytes. (A)
P-TEFb ChIP for mouse RAW264.7 Il1b and Tnf genes in the presence of LY-294002 inhibition. (B) Pol II, PTEFb, S2P CTD Pol II, S2P CTD Pol II and
H3K36me3 ChIP, as indicated, for 2DG-treated mouse BMDM. The BMDM were stimulated for indicated times with LPS plus or minus 3 h
pretreatment with 2–DG.
doi:10.1371/journal.pone.0070622.g007
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Additional LPS stimulus can resume the transcription of the
paused complexes on IL1B by means of gene specific P-TEFb
recruitment, enabling resistance to endotoxin tolerance. Since
nucleosome positioning controls promoter accessibility [64], we
mapped promoter nucleosome distribution, as well as LPS-
dependent temporal depletion and deposition at the end of the
transient phase of TNF and IL1B transcription. Our data reveal
cell type specific NDR upstream of the highly phased +1
nucleosome on both genes. Untransfected HEK293, which do
not transcribe IL1B, revealed a highly phased 21 nucleosome
within the NDR in the vicinity of the TSS. Transfection of Spi1
with TRAF6 and IRF8 (acting as an LPS surrogate) induces
displacement of this 21 nucleosome. We hypothesize that this
displaceable nucleosome serves as a control check-point mediating
cell type and stimulus-dependent access to the transcription
machinery at the IL1B promoter. Inhibition of transcription factor
activation/recruitment to gene promoters in THP-1 cells similarly
abolished LPS induced nucleosome clearance in a gene specific
manner. While the inhibition of NF-kB had a pronounced effect
on both IL1B and TNF, C/EBPb inhibition only affected
nucleosomes on the IL1B promoter. Our data provide a functional
link between transcription factor activation and nucleosome
clearance from these LPS-induced IE promoters.
Spatial-temporal analysis of chromatin modifications through-
out the gene revealed monocyte-specific/stimulation-independent
absence of inhibitory H3K27me3 throughout the entire length of
both genes, contrasting the situation in cell types that do not
transcribe these genes (Figure 3B). The H3K4me3 promoter mark
present at the +1 nucleosome on TNF in unstimulated cells did not
significantly increase 1 h post-stimulation. However, significant
enrichment was observed at +1 and extending throughout the
transcribed gene body during shutdown at 5 h. We argue that high
levels of transcribing polymerases impede nucleosome deposition
and modification throughout the transcribed region. At the end of
transient transcription, nucleosomes were observed to be re-
deposited to their original positions and became subject to histone
modifiers. Our data reveal that the cell type-restricted expression
of IL1B is due to the presence of the monocyte-specific
differentiation factor Spi1, which binds constitutively to the IL1B
promoter and enhancer in resting THP-1, poising the gene for
induction. This binding is necessary, but insufficient, for LPS-
mediated IL1B induction in THP-1 cells, as well as in HEK293
cells for which Spi1 in the absence of surrogate stimulation does
not cause strong nucleosome clearance. We speculate that
stimulation-dependent binding of NF-kB and C/EBPb to the
DNA loop-dependent proximity of constitutively bound Spi1,
facilitates induction of IL1B via nucleosome remodeling. This is
especially true for the 21 nucleosome, which appears to occlude
TSS-proximal binding of TBP. This contrasts with TNF, in which
the 21 nucleosome resides further upstream, permitting TBP
access. The mechanism by which this occurs could depend upon
the observed stimulation-dependent recruitment of p300 histone
acetyltransferase (Figure 6A) and the SNF2b/BRG1 SWI/SNF
chromatin remodeling enzyme (Figure S5J) by activated transcrip-
tion factors. Both NF-kB [65,66] and C/EBPb [67,68], as well as
HIF-1 [69,70] have been reported to directly recruit both SWI/
SNF remodelers and p300 histone acetyltransferases. This would
enable the nucleosome clearance required for Spi1-assisted
recruitment of TBP to TATA box DNA. Regardless, as suggested
by ectopic expression in HEK293 cells (Figure 4E), nucleosome
remodeling depends upon the integrity of the Spi1 N-terminal
domain in concert with the activation of key transcription factors,
and appears to be necessary for TBP recruitment. These
cooperative associations facilitate the subsequent assembly of the
paused Pol II complex and regulate its release by P-TEFb in order
to transition into productive elongation. The presence of highly
dynamic Pol II further enhances the open promoter by competing
with nucleosome re-deposition [71].
In summary, IL1B and TNF differ in the initial promoter state
for unstimulated cells, with Spi1 and TBP possibly playing central
roles for IL1B. Strikingly, during maximal initial expression (1 h)
the chromatin architecture of the two genes looks quite similar.
However, at 5 h distinct new architectures are established,
resulting in TNF tolerance and establishing paused Pol II
competent for re-stimulation on IL1B (Figure 8B). Importantly,
we observe that these two NF-kB-dependent genes reveal
numerous distinctions that may be reflective of known differences
that exist for the cell source and function of their gene products.
IL-1b protein expression is known to be more restricted to
monocytes than is TNFa [37], likely dependent upon the
requirement for Spi1 and its role in de novo recruitment of TBP.
IL1B is also dependent upon LPS-activated C/EBPb, which
cooperates with NF-kB and Spi1 to induce transcription, likely in
the context of a specific chromatin architecture involving the
interaction between the promoter and a distal far-upstream
enhancer.
It remains unclear, other than the requirement for Spi1 on
IL1B, which factors are truly relevant for the priming of LPS
responsive enhancers. The induction of TNF in cells which do not
express Spi-1, argues against a universal role for Spi1 in LPS
priming. LPS signal transduction involves Toll-IL-1 Receptor
(TIR) signaling to activate pan-specific transcription factors, such
as NF-kB and c-Jun [72] via IkB and MAP kinases, shared by
various receptors found on a wide variety of cells. TLR4, the
primary LPS receptor, is functional on a variety of non-myeloid
cells, including basophils, keratinocytes, and epithelial cells [73].
NF-kB is also abundant in numerous cell types and plays a critical
activation role in both TNF and IL1B gene induction. However,
IL1B induction in monocytes also requires C/EBPb, a protein
more widely expressed than Spi1, but highly expressed in
monocytic cells. Consequently, LPS signaling is not restricted to
the myeloid/macrophage lineage, arguing that LPS-specific
genomic programming may only require the appropriate recep-
tor/signaling pathway and a receptive target gene. Therefore,
priming of the gene may only be dependent upon its ability to
present an open NDR promoter for Pol II recruitment. For IL1B
in monocytes exposure may be primarily the binding of Spi1. In
the case of TNF, promoter exposure may be accomplished either
by monocyte or non-monocyte transcription factors, depending
upon the cell-type.
The distinct functions of TNFa and IL-1b proteins are
supported by the recent advent of specific therapeutic blockers,
which reveal that there are diseases in which one or the other
results in asymmetric efficacy, and occasionally asymmetric
contraindication [74,75,76]. This is somewhat surprising, since
both proteins activate similar signaling pathways in target cells.
Consequently, it is reasonable that such functional differences
might result from the differential gene regulation for two similar,
but non-identical, immune effectors.
Materials and Methods
Cell Culture
THP-1 and Hut102 (ATCC) were cultured in RPMI.
RAW264.7 (ATCC) were cultured in DMEM. HEK293 and
MG63 (ATCC) were cultured in EMEM. All media was from
Corning-Medaitech Cellgro. Cultures were all supplemented with
10% heat-inactivated fetal bovine serum (FBS, Hyclone), 1%
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Penicillin/Streptomycin Solution (Cellgro 30-002-CI). THP-1
cultures also contained 0.05 mM 2-mercaptoethanol (21985-023,
Invitrogen). Adult human elutriated monocytes (Advanced Bio-
technologies) and were cultured in DMEM with 20% FBS (Fisher),
1% Penicillin/Streptomycin and 50 mg/ml Gentamicin (MP
Biomedicals) for 7 days until macrophage monolayer was
established. On day 7 and 8, 90% of the old media was replaced
with 10 ml of fresh media to remove all non-adherent cells. LPS
stimulation was conducted on day 9 of cell culture. Murine bone
marrow-derived macrophages (BMDM) from C57BL/6 mice
(Harlan Laboratories, UK) were differentiated for 7 d in M-CSF
(20% v/v) and L929 mouse fibroblast supernatant prior to
Figure 8. Proposed mechanism for LPS mediates induction of IL1B and TNF in monocytes. (A) Summary of ChIP kinetics for some key
features of IL1B and TNF in THP-1 monocytes. Pol II, TBP and Spi1 are as indicated. Histone modifications at specific locations detailed in the text are
labeled. Key nucleosomes are designated by position relative to the TSS (22,21, +1). (B) Models for IL1B and TNF gene regulation. Red text highlights
important distinctions between the two genes along the induction kinetic. Nucleosomes are marked with stars (acetylation) and spheres
(trimethylation) representative of significant increases in modification. Darkly colored nucleosomes are likely to be less dynamic and suggestive of
impediments to gene expression. The indicated locations of Pol II are represented by various levels of intensity, reflecting the relative degree of
proposed dwelling on DNA. Arrowheads on Pol II represent the relative efficiency of elongation, as indicated by the length of the associated dotted
line. (C) Schematic representation of the relationships between metabolic pathways involved in IL1B gene activation, summarizing key elements from
this study and that recently reported elsewhere [56].
doi:10.1371/journal.pone.0070622.g008
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experimental treatments. The BMDM were stimulated with 100
ng/ml LPS plus or minus 2–DG (1 mM) pretreatment for 3 h. All
experiments involving mice were carried out with prior ethical
approval from the Trinity College Dublin Animal Research Ethics
Committee.
Reagents and Treatment Conditions
In all experiments, monocytes were stimulated with 1 mg/ml of
E. coli 055:B5 lipopolysaccharide (LPS) (Sigma) for indicated time
periods. In the case of re-stimulation experiments, cells were
initially stimulated with 1 mg/ml of LPS and then re-stimulated
with additional 1 mg/ml of LPS without washing the media. All
inhibitors used in the study were applied 1 h prior to LPS
treatments in following concentrations; 1 mM/ml MG (Calbio-
chem), 10 mM/ml U0126 (Promega), 50 mM/ml 5,6-Dichloro-
benzimidazole 1-b-D-ribofuranoside (DRB) (Sigma) 10 mM/ml
BMS-345541 I KK Inhibitor III (Calbiochem) and 25 mM
LY294002 (Calbiochem).
Chromatin Immuno-precipitation (ChIP)
ChIP was performed using a modification of the Millipore/
Upstate protocol (MCPROTO407). Fold enrichment was calcu-
lated based on Ct as 2(DCt), where DCt= (Ct Input – Ct IP). Final
enrichment values were adjusted by subtraction of the nonspecific
IgG antibody binding. Condensed data profiles are presented for
many figures. Detailed statistical results for all such profiles appear
in as Supporting Information, as reference in text. A total of
16107 cells were fixed in 1% formaldehyde (Fisher) for 10 min at
room temperature. Cross-linking was inhibited by addition of
glycine to a final concentration 0.125 M. Samples were sonicated
(to generate DNA fragments of 250 base pairs (bp) average length)
on ice using a Fisher Scientific Sonic Model 100 Dismembrator, as
follows: 15625 strokes at 100% power followed by 3625 stokes at
50% power and centrifuged at 12000 RPM for 10 min.
Chromatin from 56106 cells was diluted 7-fold in ChIP Dilution
Buffer (0.01% SDS, 1.1% Triton X-100, 1.2 mM EDTA,
16.7 mM Tris-HCl, pH8.1, 167 mM NaCl), pre-cleared with
protein Agarose/Salmon Sperm DNA beads (Protein G Agarose,
16–201 Millipore, Protein A Agarose 16–157 Millipore; IgM
A4540 Sigma-Aldrich) for 30 min at 4uC, and centrifuged at
10,000 RPM for 2 min. Chromatin supernatants were incubated
at 4uC overnight with respective antibodies (Table S2 in File S1).
Aliquots for INPUT and non-specific IgG control samples were
included with each experiment. Primer pairs against various
regions of genes were designed using the PrimerQuest software
available at the Integrated DNA technologies website (Tables S3–
S8 in File S1). The size of the PCR products ranges between 67
and 192 bp overall (67 and 94 bp in the immediate vicinity of the
IL1B promoter). Twenty microliter qPCR reactions containing 2x
Maxima SYBR Green/ROX qPCR Master Mix (K0223,
Fermentas), 250 nM of primers and 3 ml of precipitated DNA
were set up in Fast 96-Well Reaction Plates (Applied Biosystems).
qPCR reactions were carried out in a StepOnePlus Applied
Biosystems Real Time Instrument. High-density overlapping
qPCR amplicons, generated using closely-spaced primers (Tables
S3, S5 in File S1) and fine fragmentation of chromatin [77],
provided sufficient resolution for ChIP analysis to permit
reproducible relative discrimination of peak maxima that exceed
that which would be derived from the analysis of a single isolated
PCR primer. However, it should be emphasized that although the
x-axis positions are not absolute, specific locations, such as the
binding sites for Spi1, TBP, and NF-kB are precisely known from
previous studies [6,9,10]. These precisely located binding sites,
which are associated with highly characterized nucleotide
sequences serve as positional reference points. Such reference
points are critical with respect to the results presented in Figure 3A,
where the relative distribution of the peaks with respect to each
other and the known reference points are not only reproducible,
but also correspond to the distributions commonly observed in the
vicinity of transcription initiation for a majority of metazoan
genes. A minimum of two and a maximum of four completely
independent experimental replicates were executed. However, the
data presented are single experiments representative of the results.
RNA Expression Analyses
16106 cells were plated into 6-well plates (Falcon). Following
stimulation, cell pellets were resuspended in 500 ml of TRIzol
reagent (Invitrogen). RNA was converted to cDNA using GoScript
Reverse Transcription System (Promega A5001). Specific primers
(Table S7 in File S1) were used to quantify gene expression via
qPCR, as described above for ChIP. Relative mRNA levels were
calculated using DDCt method using b b-2-microtubulin and
18srRNA as endogenous controls, and presented as the ratio in
resting vs. LPS-treated cells. In certain experiments RNA was
directly subjected to an RT-PCR utilizing the Access RT-PCR
system (Promega). After addition of 170 ml of Chloroform (C606-
1, Fisher) samples were vortexed, incubated at room temperature
for 15 min, and centrifuged for 15 min at 13000 RPM in 4uC.
Aqueous layer was removed, combined with equal volume of
Isopropanol (BP2632-4, Fisher), 1 ml of Glycogen (9510, Ambion)
and centrifuged for 10 min 13000 RPM at 4uC. Sample pellets
were washed with 500 ml of 75% Ethanol (Pharmaco-AAPER) and
centrifuged for 10 min in room temperature at 14000. Air-dried
pellets were resuspended in 30 ml of RNAse free water and
subjected to DNAse treatments using Turbo DNA-free reagents
(AM1907, Ambion) according to the manufacturer instructions in
order to eliminate genomic DNA contamination.
In Vitro Protein Interaction Assays
GST-Spi1 fusion proteins were generated as previously reported
[78].
Transfection Constructs
Luciferase reporter XT-Luc IL1B, wild type IRF8 and mutant
IRF8Y211F were as described [42]. Expression plasmids for wild-
type C/EBPb and the truncated C/EBPbDSPL, were constructed
and characterized as reported [8]. Expression plasmids expressing
wild-type Spi1 and the dnSpi1 deletion mutant were constructed
as described [9,79]. The MHCkB-Luc reporter is as described
[80,81].
Transient Transfection
HEK293 cells were seeded into 24 well plates to 60–70%
confluency. Reporter and expression plasmids were transfected
with FUGENE 6 Transfection Reagent (Roche 11814443001) at
3 ml of reagent per mg of DNA, according to the manufacturer’s
instructions. Individual expression vectors were transfected as
follows: 0.05 mg of Spi1 and 0.1 ug of TRAF6, IRF8, C/EBPb
and NF-kB into 24 well plates containing 500 ml of media. Total
amount of transfected DNA was maintained constant for each
experiment by addition of empty vector. Endogenous IL1B studies
were conducted in 6 well culture plates with the amount of
transfected material adjusted 3 fold.
Luciferase Assays
At 24 h after transfection, cells were lysed with 60 ml of 1X cell
lysis buffer in each well (24 well plate) and shaken for 20 min at
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RT. 20 ml of supernatant from each well was used for luciferase
assay using Luciferase Assay System (Promega E1501) and
analyzed by Veritas Microplate Luminometer and Software.
Chromatin Conformation Capture (3C)
3C was performed using a modification of the protocol
described in [82]. A total of 1.56106 cells were fixed in 2%
formaldehyde (Fisher) for 10 min at room temperature. Cross-
linking was inhibited by addition of glycine to a final concentration
0.125 M. Cell pellets were collected into 15 ml Falcon tubes and
washed twice with ice cold PBS and resuspended in Lysis Buffer
(10 mM Tris-HCl pH 8.0, 10 mM NaCl, 0.2% NP-40, supple-
mented with 1 mM PMSF and protease inhibitor cocktail (Sigma)
in 1:500 dilution) on ice for 90 min. Samples were centrifuged at
1800 rpm for 5 min, resuspended in 900 ml of 1.26NEB4 (diluted
with 0.3% SDS), and transferred into 1.5 ml Eppendorf tubes.
Nuclear lysates were incubated for 1 hr at 37uC with moderate
vortexing. 180 ml of Triton X-100 (final concentration of 1.8%)
was added and samples were incubated for additional 1 hr at
37uC. Portion of chromatin (1 ug) was removed and treated
overnight with MfeI (40 Unit) at 37uC. Lysates were treated with
1.6% SDS and incubated 60uC for 20 min. 47.5 ml of Lysates were
used for ligation reaction (40 ml 10% Triton X-100, 40 ml ligase
buffer (10x), 270 ml H2O, 2.5 ml T4 DNA ligase) that was carried
out for 16 hours at 16uC. Next, 100 ug/ml of proteinase K was
added to samples that were subsequently incubated overnight at
65uC. Next day, samples were treated with RNase A (0.5 ug/ml)
for 30 min at 37uC and DNA was extracted. PCR products were
amplified using GoTaq PCR Core System I (M7660, Promega)
and analyzed by 2% agarose gel electrophoresis. Resolved
fragments were then eluted and subjected to DNA sequencing in
order to verify the identity of the ligation products.
Site Directed Mutagenesis
XT-Luc binding site mutation reporter constructs: C/EBPb I
region binding site (XT-I c/g-Luc); NF-KB site at position 2300
(XT-300kB-Luc); and the double I(c/g)/2300 kB were generated
using QuickChange XL Site-Directed Mutagenesis Kit (Strata-
gene 200516) using appropriately mutated primer sequences.
Western Blotting
Western blots were performed by standard protocols. Protein
concentrations were determined using Pierce BCA Protein Assay
Kit (Thermoscientific 23227).
Supporting Information
Figure S1 IL-1 and TNFa mRNA Expression Measured
by QPCR in Various Cell Types. (A) LPS-treated human
THP-1 monocytes (Low resolution 0–27 h kinetics). (B) LPS-
treated ex vivo-differentiated mouse peripheral blood monocytes.
(C) LPS-treated mouse RAW264.7 monocytes. (D) Unstimulated
human THP-1 monocytes evaluated for splicing using informative
primers. (E) LPS-treated human THP-1 monocytes (High
resolution 0–3 h kinetics).
(TIF)
Figure S2 Pol II and TBP ChIP Comparing Human and
Mouse Genes from LPS-treated Cells. (A) Comparison of
Pol II and TBP occupancy kinetics on Il1 and Tnf genes for LPS-
treated mouse RAW264.7 monocytes. (B) Representative bar
graphs used to generate plots for Pol II ChIP in Figures 1C and
S2A. (C) Pol II occupancy kinetics on JUNB and HIST1H4K genes
for LPS-treated human THP-1 monocytes.
(TIF)
Figure S3 ChIP Comparing Occupancy of Various
General Transcription Factors and Modifications from
LPS-treated Cells. (A) LPS-treated RAW264.7 monocytes
(Averaged profiles). (B) LPS-treated ex vivo-differentiated mouse
BMDM (Averaged profiles derived from data shown in Figure 7B).
(TIF)
Figure S4 ChIP used for Comparative Nucleosome
Analysis of IL1B and TNF in Various Cells. Summary
profiles comparing nucleosome modifications for LPS-treated
human THP-1 cells with untreated HEK293 pre-neuronal cells,
Hut102 cutaneous T lymphocytes and MG63 osteoblastic cells.
(TIF)
Figure S5 Transcription Factor-mediated Looping Be-
tween the IL1B Distal Enhancer and Promoter May
Depend Upon the Binding of C/EBPb. (A) IL1B mRNA
expression in HEK293 cells transfected with various expression
vectors. (B) IL1B and TNF mRNA expression in HEK293 cells
transfected with Spi1 expression vector. (C) IL1B and TNF mRNA
expression kinetics in THP-1 cells treated with MG132 NF-kB/
proteosome inhibitor. (D) Effect of IKKb inhibitor on IL1B and
TNF mRNA expression in THP-1 monocytes. (E) Effect of various
inhibitors on IL1B and TNF mRNA expression in THP-1 and
RAW264.7 monocytes. (F) IL1BXT-Luc reporter activity for
ectopic expression of indicated factors transfected into HEK293.
(G) IL1BXT-Luc and MHCkB reporter activity in RAW264.7
transfected with IkBa super repressor (IkBaSR). (H) Controls for
Spi1 ectopic expression in transfected HEK293. (I) Glutathione S-
transferase pull-downs demonstrate in vitro protein-protein inter-
action between the DNA binding domain of Spi1 and various
transcription factors, including NF-kBp65.
(TIF)
File S1 Table S1. Relative levels of 21 and +1 nucleosome
marks in relationship to amount of H3 on IL1B in THP1 cells.
Table S2. Antibodies used for ChIP and Western blots. Table S3.
Human TNF primer sequences. Table S4. Human JUNB and
HIST1H4K primer sequences. Table S5. Human IL1B primer
sequences. Table S6. Murine Il1b and Tnf ChIP primer sequences.
Table S7. mRNA analysis and qPCR primer sequences. Table S8.
Human IL1B 3C primer sequences.
(PDF)
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